Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming ... Sullivan has international experience in the pharmaceutical and biotech industry, having lived and worked in ...

The Board of Directors has decided to nominate Dr. Elaine Sullivan at the AGM for the appointment as a new Non-Executive Director for a term of four years. The terms of Mrs. Deborah Jorn and Mr.

Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming ... “ZEAL”), a biotechnology company focused on the discovery and development of peptide-based medicines, since ...

Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, April 23, 2025: Pharming Group ...

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe ...

Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, April 23, 2025: Pharming ...

Leiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2025 ...

Pharming Group N.V. (Pharming), a global biopharmaceutical company, announces that the National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja ...

The latest price target for Pharming (NASDAQ:PHAR) was reported by HC Wainwright & Co. on March 21, 2025. The analyst firm set a price target for $37.00 expecting PHAR to rise to within 12 months ...

Pharming Group delivered strong financial results in Q4 2024 and provided an optimistic 2025 revenue guidance of $315 million ...

Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, April 23, 2025: Pharming Group ...